Global Circulating Tumor Cells Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Global Circulating Tumor Cells Market by Manufacturers, Countries, Type and Application, Forecast to 2023


  • Products Id :- GIR1442
  • |
  • Pages: 152
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.

Scope of the Report:

This report studies the Circulating Tumor Cells market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Circulating Tumor Cells market by product type and applications/end industries.

The classification of Circulating Tumor Cells (CTCs) products includes CTC enrichment, CTC detection and CTC analysis, and the revenue proportion of CTC enrichment in 2016 is about 43.74%.

North America is the largest supplier of CTCs Products, with a revenue market share nearly 53.18% in 2016. Europe is the second largest supplier of CTCs products, enjoying revenue market share nearly 28.01% in 2016.

Growth of the global CTCs market is mainly driven by increasing prevalence of cancer globally. Increasing prevalence of various cancers such as breast cancer, prostate cancer and lung cancer is expected to drive growth of the CTCs test market over the forecast period.

FDA approvals for various non-invasive diagnostic tests to detect cancer are set to define the regulatory landscape for CTCs tests. Companies in the CTCs market space are expected to invest more on test kits and cost containment procedures to provide innovative diagnostic solutions to the oncologists and physicians for detecting metastasis.

The global Circulating Tumor Cells market is valued at 1220 million USD in 2017 and is expected to reach 2740 million USD by the end of 2023, growing at a CAGR of 14.5% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Circulating Tumor Cells.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Menarini-Silicon Biosystems

Qiagen?Adnagen?

Clearbridge Biomedics

Celsee

Fluidigm

ApoCell

Greiner Bio-one GmbH

Advanced Cell Diagnostics

Aviva Biosciences

Fluxion Biosciences

Sysmex Corporation

Epic Sciences

Cynvenio

CytoTrack

Ikonisys

Vortex BioSciences

Gilupi

Biocept

ScreenCell

ANGLE

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

CTC Enrichment

CTC Detection

CTC Analysis

Market Segment by Applications, can be divided into

Breast Cancer

Prostate Cancer

Colorectal Cancer

Other



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

1 Circulating Tumor Cells Market Overview

1.1 Product Overview and Scope of Circulating Tumor Cells

1.2 Classification of Circulating Tumor Cells by Types

1.2.1 Global Circulating Tumor Cells Revenue Comparison by Types (2017-2023)

1.2.2 Global Circulating Tumor Cells Revenue Market Share by Types in 2017

1.2.3 CTC Enrichment

1.2.4 CTC Detection

1.2.5 CTC Analysis

1.3 Global Circulating Tumor Cells Market by Application

1.3.1 Global Circulating Tumor Cells Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Breast Cancer

1.3.3 Prostate Cancer

1.3.4 Colorectal Cancer

1.3.5 Other

1.4 Global Circulating Tumor Cells Market by Regions

1.4.1 Global Circulating Tumor Cells Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Circulating Tumor Cells Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Circulating Tumor Cells Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Circulating Tumor Cells Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Circulating Tumor Cells Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Circulating Tumor Cells Status and Prospect (2013-2023)

1.5 Global Market Size of Circulating Tumor Cells (2013-2023)

2 Manufacturers Profiles

2.1 Menarini-Silicon Biosystems

2.1.1 Business Overview

2.1.2 Circulating Tumor Cells Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

2.2 Qiagen?Adnagen?

2.2.1 Business Overview

2.2.2 Circulating Tumor Cells Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Qiagen?Adnagen? Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

2.3 Clearbridge Biomedics

2.3.1 Business Overview

2.3.2 Circulating Tumor Cells Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Clearbridge Biomedics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

2.4 Celsee

2.4.1 Business Overview

2.4.2 Circulating Tumor Cells Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Celsee Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

2.5 Fluidigm

2.5.1 Business Overview

2.5.2 Circulating Tumor Cells Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Fluidigm Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

2.6 ApoCell

2.6.1 Business Overview

2.6.2 Circulating Tumor Cells Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 ApoCell Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

2.7 Greiner Bio-one GmbH

2.7.1 Business Overview

2.7.2 Circulating Tumor Cells Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Greiner Bio-one GmbH Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

2.8 Advanced Cell Diagnostics

2.8.1 Business Overview

2.8.2 Circulating Tumor Cells Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Advanced Cell Diagnostics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

2.9 Aviva Biosciences

2.9.1 Business Overview

2.9.2 Circulating Tumor Cells Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Aviva Biosciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

2.10 Fluxion Biosciences

2.10.1 Business Overview

2.10.2 Circulating Tumor Cells Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Fluxion Biosciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

2.11 Sysmex Corporation

2.11.1 Business Overview

2.11.2 Circulating Tumor Cells Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Sysmex Corporation Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

2.12 Epic Sciences

2.12.1 Business Overview

2.12.2 Circulating Tumor Cells Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Epic Sciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

2.13 Cynvenio

2.13.1 Business Overview

2.13.2 Circulating Tumor Cells Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Cynvenio Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

2.14 CytoTrack

2.14.1 Business Overview

2.14.2 Circulating Tumor Cells Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 CytoTrack Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

2.15 Ikonisys

2.15.1 Business Overview

2.15.2 Circulating Tumor Cells Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Ikonisys Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

2.16 Vortex BioSciences

2.16.1 Business Overview

2.16.2 Circulating Tumor Cells Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Vortex BioSciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

2.17 Gilupi

2.17.1 Business Overview

2.17.2 Circulating Tumor Cells Type and Applications

2.17.2.1 Product A

2.17.2.2 Product B

2.17.3 Gilupi Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

2.18 Biocept

2.18.1 Business Overview

2.18.2 Circulating Tumor Cells Type and Applications

2.18.2.1 Product A

2.18.2.2 Product B

2.18.3 Biocept Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

2.19 ScreenCell

2.19.1 Business Overview

2.19.2 Circulating Tumor Cells Type and Applications

2.19.2.1 Product A

2.19.2.2 Product B

2.19.3 ScreenCell Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

2.20 ANGLE

2.20.1 Business Overview

2.20.2 Circulating Tumor Cells Type and Applications

2.20.2.1 Product A

2.20.2.2 Product B

2.20.3 ANGLE Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

3 Global Circulating Tumor Cells Market Competition, by Players

3.1 Global Circulating Tumor Cells Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Circulating Tumor Cells Players Market Share

3.2.2 Top 10 Circulating Tumor Cells Players Market Share

3.3 Market Competition Trend

4 Global Circulating Tumor Cells Market Size by Regions

4.1 Global Circulating Tumor Cells Revenue and Market Share by Regions

4.2 North America Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

4.3 Europe Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

4.5 South America Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

5 North America Circulating Tumor Cells Revenue by Countries

5.1 North America Circulating Tumor Cells Revenue by Countries (2013-2018)

5.2 USA Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

5.3 Canada Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

5.4 Mexico Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

6 Europe Circulating Tumor Cells Revenue by Countries

6.1 Europe Circulating Tumor Cells Revenue by Countries (2013-2018)

6.2 Germany Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

6.3 UK Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

6.4 France Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

6.5 Russia Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

6.6 Italy Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Circulating Tumor Cells Revenue by Countries

7.1 Asia-Pacific Circulating Tumor Cells Revenue by Countries (2013-2018)

7.2 China Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

7.3 Japan Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

7.4 Korea Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

7.5 India Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

8 South America Circulating Tumor Cells Revenue by Countries

8.1 South America Circulating Tumor Cells Revenue by Countries (2013-2018)

8.2 Brazil Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

8.3 Argentina Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

8.4 Colombia Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Circulating Tumor Cells by Countries

9.1 Middle East and Africa Circulating Tumor Cells Revenue by Countries (2013-2018)

9.2 Saudi Arabia Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

9.3 UAE Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

9.4 Egypt Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

9.5 Nigeria Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

9.6 South Africa Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

10 Global Circulating Tumor Cells Market Segment by Type

10.1 Global Circulating Tumor Cells Revenue and Market Share by Type (2013-2018)

10.2 Global Circulating Tumor Cells Market Forecast by Type (2018-2023)

10.3 CTC Enrichment Revenue Growth Rate (2013-2023)

10.4 CTC Detection Revenue Growth Rate (2013-2023)

10.5 CTC Analysis Revenue Growth Rate (2013-2023)

11 Global Circulating Tumor Cells Market Segment by Application

11.1 Global Circulating Tumor Cells Revenue Market Share by Application (2013-2018)

11.2 Circulating Tumor Cells Market Forecast by Application (2018-2023)

11.3 Breast Cancer Revenue Growth (2013-2018)

11.4 Prostate Cancer Revenue Growth (2013-2018)

11.5 Colorectal Cancer Revenue Growth (2013-2018)

11.6 Other Revenue Growth (2013-2018)

12 Global Circulating Tumor Cells Market Size Forecast (2018-2023)

12.1 Global Circulating Tumor Cells Market Size Forecast (2018-2023)

12.2 Global Circulating Tumor Cells Market Forecast by Regions (2018-2023)

12.3 North America Circulating Tumor Cells Revenue Market Forecast (2018-2023)

12.4 Europe Circulating Tumor Cells Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Circulating Tumor Cells Revenue Market Forecast (2018-2023)

12.6 South America Circulating Tumor Cells Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Circulating Tumor Cells Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Circulating Tumor Cells Picture

Table Product Specifications of Circulating Tumor Cells

Table Global Circulating Tumor Cells and Revenue (Million USD) Market Split by Product Type

Figure Global Circulating Tumor Cells Revenue Market Share by Types in 2017

Figure CTC Enrichment Picture

Figure CTC Detection Picture

Figure CTC Analysis Picture

Table Global Circulating Tumor Cells Revenue (Million USD) by Application (2013-2023)

Figure Circulating Tumor Cells Revenue Market Share by Applications in 2017

Figure Breast Cancer Picture

Figure Prostate Cancer Picture

Figure Colorectal Cancer Picture

Figure Other Picture

Table Global Market Circulating Tumor Cells Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2013-2023)

Table Menarini-Silicon Biosystems Basic Information, Manufacturing Base and Competitors

Table Menarini-Silicon Biosystems Circulating Tumor Cells Type and Applications

Table Menarini-Silicon Biosystems Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

Table Qiagen?Adnagen? Basic Information, Manufacturing Base and Competitors

Table Qiagen?Adnagen? Circulating Tumor Cells Type and Applications

Table Qiagen?Adnagen? Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

Table Clearbridge Biomedics Basic Information, Manufacturing Base and Competitors

Table Clearbridge Biomedics Circulating Tumor Cells Type and Applications

Table Clearbridge Biomedics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

Table Celsee Basic Information, Manufacturing Base and Competitors

Table Celsee Circulating Tumor Cells Type and Applications

Table Celsee Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

Table Fluidigm Basic Information, Manufacturing Base and Competitors

Table Fluidigm Circulating Tumor Cells Type and Applications

Table Fluidigm Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

Table ApoCell Basic Information, Manufacturing Base and Competitors

Table ApoCell Circulating Tumor Cells Type and Applications

Table ApoCell Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

Table Greiner Bio-one GmbH Basic Information, Manufacturing Base and Competitors

Table Greiner Bio-one GmbH Circulating Tumor Cells Type and Applications

Table Greiner Bio-one GmbH Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

Table Advanced Cell Diagnostics Basic Information, Manufacturing Base and Competitors

Table Advanced Cell Diagnostics Circulating Tumor Cells Type and Applications

Table Advanced Cell Diagnostics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

Table Aviva Biosciences Basic Information, Manufacturing Base and Competitors

Table Aviva Biosciences Circulating Tumor Cells Type and Applications

Table Aviva Biosciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

Table Fluxion Biosciences Basic Information, Manufacturing Base and Competitors

Table Fluxion Biosciences Circulating Tumor Cells Type and Applications

Table Fluxion Biosciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

Table Sysmex Corporation Basic Information, Manufacturing Base and Competitors

Table Sysmex Corporation Circulating Tumor Cells Type and Applications

Table Sysmex Corporation Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

Table Epic Sciences Basic Information, Manufacturing Base and Competitors

Table Epic Sciences Circulating Tumor Cells Type and Applications

Table Epic Sciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

Table Cynvenio Basic Information, Manufacturing Base and Competitors

Table Cynvenio Circulating Tumor Cells Type and Applications

Table Cynvenio Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

Table CytoTrack Basic Information, Manufacturing Base and Competitors

Table CytoTrack Circulating Tumor Cells Type and Applications

Table CytoTrack Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

Table Ikonisys Basic Information, Manufacturing Base and Competitors

Table Ikonisys Circulating Tumor Cells Type and Applications

Table Ikonisys Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

Table Vortex BioSciences Basic Information, Manufacturing Base and Competitors

Table Vortex BioSciences Circulating Tumor Cells Type and Applications

Table Vortex BioSciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

Table Gilupi Basic Information, Manufacturing Base and Competitors

Table Gilupi Circulating Tumor Cells Type and Applications

Table Gilupi Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

Table Biocept Basic Information, Manufacturing Base and Competitors

Table Biocept Circulating Tumor Cells Type and Applications

Table Biocept Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

Table ScreenCell Basic Information, Manufacturing Base and Competitors

Table ScreenCell Circulating Tumor Cells Type and Applications

Table ScreenCell Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

Table ANGLE Basic Information, Manufacturing Base and Competitors

Table ANGLE Circulating Tumor Cells Type and Applications

Table ANGLE Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)

Table Global Circulating Tumor Cells Revenue (Million USD) by Players (2013-2018)

Table Global Circulating Tumor Cells Revenue Share by Players (2013-2018)

Figure Global Circulating Tumor Cells Revenue Share by Players in 2016

Figure Global Circulating Tumor Cells Revenue Share by Players in 2017

Figure Global Top 5 Players Circulating Tumor Cells Revenue Market Share in 2017

Figure Global Top 10 Players Circulating Tumor Cells Revenue Market Share in 2017

Figure Global Circulating Tumor Cells Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Circulating Tumor Cells Revenue (Million USD) by Regions (2013-2018)

Table Global Circulating Tumor Cells Revenue Market Share by Regions (2013-2018)

Figure Global Circulating Tumor Cells Revenue Market Share by Regions (2013-2018)

Figure Global Circulating Tumor Cells Revenue Market Share by Regions in 2017

Figure North America Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

Figure Europe Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

Figure South America Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

Table North America Circulating Tumor Cells Revenue by Countries (2013-2018)

Table North America Circulating Tumor Cells Revenue Market Share by Countries (2013-2018)

Figure North America Circulating Tumor Cells Revenue Market Share by Countries (2013-2018)

Figure North America Circulating Tumor Cells Revenue Market Share by Countries in 2017

Figure USA Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

Figure Canada Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

Figure Mexico Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

Table Europe Circulating Tumor Cells Revenue (Million USD) by Countries (2013-2018)

Figure Europe Circulating Tumor Cells Revenue Market Share by Countries (2013-2018)

Figure Europe Circulating Tumor Cells Revenue Market Share by Countries in 2017

Figure Germany Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

Figure UK Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

Figure France Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

Figure Russia Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

Figure Italy Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Circulating Tumor Cells Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Circulating Tumor Cells Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Circulating Tumor Cells Revenue Market Share by Countries in 2017

Figure China Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

Figure Japan Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

Figure Korea Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

Figure India Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

Table South America Circulating Tumor Cells Revenue by Countries (2013-2018)

Table South America Circulating Tumor Cells Revenue Market Share by Countries (2013-2018)

Figure South America Circulating Tumor Cells Revenue Market Share by Countries (2013-2018)

Figure South America Circulating Tumor Cells Revenue Market Share by Countries in 2017

Figure Brazil Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

Figure Argentina Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

Figure Colombia Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Circulating Tumor Cells Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Circulating Tumor Cells Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Circulating Tumor Cells Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Circulating Tumor Cells Revenue Market Share by Countries in 2017

Figure Saudi Arabia Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

Figure UAE Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

Figure Egypt Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

Figure Nigeria Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

Figure South Africa Circulating Tumor Cells Revenue and Growth Rate (2013-2018)

Table Global Circulating Tumor Cells Revenue (Million USD) by Type (2013-2018)

Table Global Circulating Tumor Cells Revenue Share by Type (2013-2018)

Figure Global Circulating Tumor Cells Revenue Share by Type (2013-2018)

Figure Global Circulating Tumor Cells Revenue Share by Type in 2017

Table Global Circulating Tumor Cells Revenue Forecast by Type (2018-2023)

Figure Global Circulating Tumor Cells Market Share Forecast by Type (2018-2023)

Figure Global CTC Enrichment Revenue Growth Rate (2013-2018)

Figure Global CTC Detection Revenue Growth Rate (2013-2018)

Figure Global CTC Analysis Revenue Growth Rate (2013-2018)

Table Global Circulating Tumor Cells Revenue by Application (2013-2018)

Table Global Circulating Tumor Cells Revenue Share by Application (2013-2018)

Figure Global Circulating Tumor Cells Revenue Share by Application (2013-2018)

Figure Global Circulating Tumor Cells Revenue Share by Application in 2017

Table Global Circulating Tumor Cells Revenue Forecast by Application (2018-2023)

Figure Global Circulating Tumor Cells Market Share Forecast by Application (2018-2023)

Figure Global Breast Cancer Revenue Growth Rate (2013-2018)

Figure Global Prostate Cancer Revenue Growth Rate (2013-2018)

Figure Global Colorectal Cancer Revenue Growth Rate (2013-2018)

Figure Global Other Revenue Growth Rate (2013-2018)

Figure Global Circulating Tumor Cells Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Circulating Tumor Cells Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Circulating Tumor Cells Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Circulating Tumor Cells Revenue Market Forecast (2018-2023)

Figure Europe Circulating Tumor Cells Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Circulating Tumor Cells Revenue Market Forecast (2018-2023)

Figure South America Circulating Tumor Cells Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Circulating Tumor Cells Revenue Market Forecast (2018-2023)

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Menarini-Silicon Biosystems

Qiagen?Adnagen?

Clearbridge Biomedics

Celsee

Fluidigm

ApoCell

Greiner Bio-one GmbH

Advanced Cell Diagnostics

Aviva Biosciences

Fluxion Biosciences

Sysmex Corporation

Epic Sciences

Cynvenio

CytoTrack

Ikonisys

Vortex BioSciences

Gilupi

Biocept

ScreenCell

ANGLE

select a license
Single User License
USD 3480 INR 238798
Site License
USD 5220 INR 358196
Corporate User License
USD 6960 INR 477595

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com